Automatic Urticaria Activity Score: Deep Learning–Based Automatic Hive Counting for Urticaria Severity Assessment

Taig Mac Carthy , Ignacio Hernández Montilla , Andy Aguilar , Rubén García Castro , Ana María González Pérez , Alejandro Vilas Sueiro , Laura Vergara de la Campa , Fernando Alfageme , Alfonso Medela
{"title":"Automatic Urticaria Activity Score: Deep Learning–Based Automatic Hive Counting for Urticaria Severity Assessment","authors":"Taig Mac Carthy ,&nbsp;Ignacio Hernández Montilla ,&nbsp;Andy Aguilar ,&nbsp;Rubén García Castro ,&nbsp;Ana María González Pérez ,&nbsp;Alejandro Vilas Sueiro ,&nbsp;Laura Vergara de la Campa ,&nbsp;Fernando Alfageme ,&nbsp;Alfonso Medela","doi":"10.1016/j.xjidi.2023.100218","DOIUrl":null,"url":null,"abstract":"<div><p>Chronic urticaria is a chronic skin disease that affects up to 1% of the general population worldwide, with chronic spontaneous urticaria accounting for more than two-thirds of all chronic urticaria cases. The Urticaria Activity Score (UAS) is a dynamic severity assessment tool that can be incorporated into daily clinical practice, as well as clinical trials for treatments. The UAS helps in measuring disease severity and guiding the therapeutic strategy. However, UAS assessment is a time-consuming and manual process, with high interobserver variability and high dependence on the observer. To tackle this issue, we introduce Automatic UAS, an automatic equivalent of UAS that deploys a deep learning, lesion-detecting model called Legit.Health-UAS-HiveNet. Our results show that our model assesses the severity of chronic urticaria cases with a performance comparable to that of expert physicians. Furthermore, the model can be implemented into CADx systems to support doctors in their clinical practice and act as a new end point in clinical trials. This proves the usefulness of artificial intelligence in the practice of evidence-based medicine; models trained on the consensus of large clinical boards have the potential of empowering clinicians in their daily practice and replacing current standard clinical end points in clinical trials.</p></div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"4 1","pages":"Article 100218"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667026723000437/pdfft?md5=4ca1bf4ece66885ed9f24601c8bff3c1&pid=1-s2.0-S2667026723000437-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JID innovations : skin science from molecules to population health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667026723000437","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic urticaria is a chronic skin disease that affects up to 1% of the general population worldwide, with chronic spontaneous urticaria accounting for more than two-thirds of all chronic urticaria cases. The Urticaria Activity Score (UAS) is a dynamic severity assessment tool that can be incorporated into daily clinical practice, as well as clinical trials for treatments. The UAS helps in measuring disease severity and guiding the therapeutic strategy. However, UAS assessment is a time-consuming and manual process, with high interobserver variability and high dependence on the observer. To tackle this issue, we introduce Automatic UAS, an automatic equivalent of UAS that deploys a deep learning, lesion-detecting model called Legit.Health-UAS-HiveNet. Our results show that our model assesses the severity of chronic urticaria cases with a performance comparable to that of expert physicians. Furthermore, the model can be implemented into CADx systems to support doctors in their clinical practice and act as a new end point in clinical trials. This proves the usefulness of artificial intelligence in the practice of evidence-based medicine; models trained on the consensus of large clinical boards have the potential of empowering clinicians in their daily practice and replacing current standard clinical end points in clinical trials.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自动荨麻疹活动评分(AUAS):用于荨麻疹严重程度评估的基于深度学习的自动蜂巢计数
慢性荨麻疹是一种慢性皮肤病,影响全世界普通人群的比例高达1%,慢性自发性荨麻疹占所有慢性荨麻疹病例的三分之二以上。荨麻疹活动评分(UAS)是一个动态的严重程度评估工具,可以纳入日常临床实践,以及临床试验治疗。UAS有助于测量疾病的严重程度和指导治疗策略。然而,UAS评估是一个耗时且手动的过程,具有高度的观察者间可变性和对观察者的高度依赖性。为了解决这个问题,我们引入了自动无人机系统,这是一种自动等效的无人机系统,它部署了一个名为Legit.Health-UAS-HiveNet的深度学习、损伤检测模型。我们的研究结果表明,我们的模型评估慢性荨麻疹病例的严重程度与专家医生的表现相当。此外,该模型可以实现到CADx系统中,以支持医生的临床实践,并作为临床试验的新终点。这证明了人工智能在循证医学实践中的有用性;在大型临床委员会共识的基础上训练的模型有可能在临床医生的日常实践中赋予他们权力,并在临床试验中取代目前的标准临床终点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.00
自引率
0.00%
发文量
0
审稿时长
8 weeks
期刊最新文献
Cover 1 Corrigendum to ‘Proteomic Profiling of CCCA Reveals Role of Humoral Immune Response Pathway and Metabolic Dysregulation’ JID Innovations, Volume 4, Issue 3, May 2024, 100263 Identification of Associations with Dermatologic Diseases through a Focused GWAS of the UK Biobank From Plant to Patient: A Historical Perspective and Review of Selected Medicinal Plants in Dermatology Spatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1